BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 22773152)

  • 1. Antibodies against human cytomegalovirus late protein UL94 in the pathogenesis of scleroderma-like skin lesions in chronic graft-versus-host disease.
    Pastano R; Dell'Agnola C; Bason C; Gigli F; Rabascio C; Puccetti A; Tinazzi E; Cetto G; Peccatori F; Martinelli G; Lunardi C
    Int Immunol; 2012 Sep; 24(9):583-91. PubMed ID: 22773152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibodies against human cytomegalovirus in the pathogenesis of systemic sclerosis: a gene array approach.
    Lunardi C; Dolcino M; Peterlana D; Bason C; Navone R; Tamassia N; Beri R; Corrocher R; Puccetti A
    PLoS Med; 2006 Jan; 3(1):e2. PubMed ID: 16318412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic sclerosis immunoglobulin G autoantibodies bind the human cytomegalovirus late protein UL94 and induce apoptosis in human endothelial cells.
    Lunardi C; Bason C; Navone R; Millo E; Damonte G; Corrocher R; Puccetti A
    Nat Med; 2000 Oct; 6(10):1183-6. PubMed ID: 11017152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of anti-NAG-2 mAb from patients' memory B cells: implications for a novel therapeutic strategy in systemic sclerosis.
    Traggiai E; Lunardi C; Bason C; Dolcino M; Tinazzi E; Corrocher R; Puccetti A
    Int Immunol; 2010 May; 22(5):367-74. PubMed ID: 20207716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IgG antibodies to human cytomegalovirus late protein UL94 in patients with systemic sclerosis.
    Namboodiri AM; Rocca KM; Pandey JP
    Autoimmunity; 2004 May; 37(3):241-4. PubMed ID: 15497459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Humoral immunity to cytomegalovirus and chronic graft-versus-host disease.
    Namboodiri AM; Nietert PJ; Wadia PP; Miklos DB; Pandey JP
    Viral Immunol; 2012 Aug; 25(4):338-40. PubMed ID: 22803743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating endothelial progenitor cells decreased in patients with sclerodermatous chronic graft-versus-host disease.
    Shimura K; Ashihara E; Shimazaki C; Matsunaga S; Taniguchi K; Uchiyama H; Matsumoto Y; Kimura S; Matsubara H; Taniwaki M; Maekawa T
    Biol Blood Marrow Transplant; 2008 Apr; 14(4):426-37. PubMed ID: 18342785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of endothelial cell damage by hCMV molecular mimicry.
    Lunardi C; Bason C; Corrocher R; Puccetti A
    Trends Immunol; 2005 Jan; 26(1):19-24. PubMed ID: 15629405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Paradigmatic Interplay between Human Cytomegalovirus and Host Immune System: Possible Involvement of Viral Antigen-Driven CD8+ T Cell Responses in Systemic Sclerosis.
    Arcangeletti MC; Maccari C; Vescovini R; Volpi R; Giuggioli D; Sighinolfi G; De Conto F; Chezzi C; Calderaro A; Ferri C
    Viruses; 2018 Sep; 10(9):. PubMed ID: 30231575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human cytomegalovirus (HCMV) UL44 and UL57 specific antibody responses in anti-HCMV-positive patients with systemic sclerosis.
    Marou E; Liaskos C; Simopoulou T; Efthymiou G; Dardiotis E; Katsiari C; Scheper T; Meyer W; Hadjigeorgiou G; Bogdanos DP; Sakkas LI
    Clin Rheumatol; 2017 Apr; 36(4):863-869. PubMed ID: 28124759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infections and autoimmunity: role of human cytomegalovirus in autoimmune endothelial cell damage.
    Dolcino M; Puccetti A; Barbieri A; Bason C; Tinazzi E; Ottria A; Patuzzo G; Martinelli N; Lunardi C
    Lupus; 2015 Apr; 24(4-5):419-32. PubMed ID: 25801885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct binding of anti-DNA topoisomerase I autoantibodies to the cell surface of fibroblasts in patients with systemic sclerosis.
    Hénault J; Tremblay M; Clément I; Raymond Y; Senécal JL
    Arthritis Rheum; 2004 Oct; 50(10):3265-74. PubMed ID: 15476238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized trial of high dose polyvalent intravenous immunoglobulin (HDIgG) vs. Cytomegalovirus (CMV) hyperimmune IgG in allogeneic hemopoietic stem cell transplants (HSCT).
    Zikos P; Van Lint MT; Lamparelli T; Gualandi F; Occhini D; Mordini N; Berisso G; Bregante S; Bacigalupo A
    Haematologica; 1998 Feb; 83(2):132-7. PubMed ID: 9549924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoantibodies to fibroblasts induce a proadhesive and proinflammatory fibroblast phenotype in patients with systemic sclerosis.
    Chizzolini C; Raschi E; Rezzonico R; Testoni C; Mallone R; Gabrielli A; Facchini A; Del Papa N; Borghi MO; Dayer JM; Meroni PL
    Arthritis Rheum; 2002 Jun; 46(6):1602-13. PubMed ID: 12115192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytomegalovirus-induced CD13-specific autoimmunity--a possible cause of chronic graft-vs-host disease.
    Soderberg C; Larsson S; Rozell BL; Sumitran-Karuppan S; Ljungman P; Moller E
    Transplantation; 1996 Feb; 61(4):600-9. PubMed ID: 8610388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoglobulin GM genes and IgG antibodies to cytomegalovirus in patients with systemic sclerosis.
    Pandey JP
    Clin Exp Rheumatol; 2004; 22(3 Suppl 33):S35-7. PubMed ID: 15344596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Mexican schedule to conduct allogeneic stem cell transplantation is related to a low risk of cytomegalovirus reactivation and disease.
    Ruiz-Argüelles GJ; Rangel JD; Ponce-de-León S; González-Déctor L; Reyes-Núñez V; Garcés-Eisele J
    Am J Hematol; 2004 Apr; 75(4):200-4. PubMed ID: 15054809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human Cytomegalovirus Protein UL94 Targets MITA to Evade the Antiviral Immune Response.
    Zou HM; Huang ZF; Yang Y; Luo WW; Wang SY; Luo MH; Fu YZ; Wang YY
    J Virol; 2020 Jun; 94(12):. PubMed ID: 32238587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allograft inflammatory factor-1 is overexpressed and induces fibroblast chemotaxis in the skin of sclerodermatous GVHD in a murine model.
    Yamamoto A; Ashihara E; Nakagawa Y; Obayashi H; Ohta M; Hara H; Adachi T; Seno T; Kadoya M; Hamaguchi M; Ishino H; Kohno M; Maekawa T; Kawahito Y
    Immunol Lett; 2011 Mar; 135(1-2):144-50. PubMed ID: 21040744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibodies to human cytomegalovirus protein UL83 in systemic sclerosis.
    Namboodiri AM; Rocca KM; Kuwana M; Pandey JP
    Clin Exp Rheumatol; 2006; 24(2):176-8. PubMed ID: 16762154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.